RecruitingPhase 2NCT05879146

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

Studying Desmoid tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Keila Torres, MD,PHD, C.S.L.P
M.D. Anderson Cancer Center
Intervention
Nirogacestat(drug)
Enrollment
40 enrolled
Eligibility
18 years · All sexes
Timeline
2024 – 2028

Study locations (1)

Collaborators

SpringWorks Therapeutics, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05879146 on ClinicalTrials.gov

Other trials for Desmoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoid tumor →

← Back to all trials